Literature DB >> 33489918

Utilization of Iodinated SpaceOAR Vue™ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal-Prostate Interface and Spare the Rectum: A Case Report.

Dylan Conroy1, Kelly Becht2, Matthew Forsthoefel1, Abigail N Pepin1, Siyuan Lei1, Abdul Rashid1, Brian Timothy Collins1, Jonathan W Lischalk1, Simeng Suy1, Nima Aghdam1, Ryan Andrew Hankins3, Sean P Collins1.   

Abstract

We describe the utilization of SpaceOAR Vue™, a new iodinated rectal spacer, during Robotic Stereotactic Body Radiation Therapy (SBRT) for a Prostate Cancer Patient with a contraindication to Magnetic Resonance Imaging. A 69-year-old Caucasian male presented with unfavorable intermediate risk prostate cancer and elected to undergo SBRT. His medical history was significant for atrial fibrillation on Rivaroxaban with a pacemaker. He was felt to be at increased risk of radiation proctitis following SBRT due to the inability to accurately contour the anterior rectal wall at the prostate apex without a treatment planning MRI and an increased risk of late rectal bleeding due to prescribed anticoagulants. In this case report, we discuss the technical aspects of appropriate placement and treatment planning for utilizing SpaceOAR Vue™ with Robotic SBRT.
Copyright © 2021 Conroy, Becht, Forsthoefel, Pepin, Lei, Rashid, Collins, Lischalk, Suy, Aghdam, Hankins and Collins.

Entities:  

Keywords:  SpaceOAR Vue; magnetic resonance imaging; prostate cancer; stereotactic body radiation therapy; urethrogram

Year:  2021        PMID: 33489918      PMCID: PMC7817609          DOI: 10.3389/fonc.2020.607698

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  34 in total

1.  (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device.

Authors:  Jean Pouliot; Michele Aubin; Katja M Langen; Yu-Ming Liu; Barby Pickett; Katsuto Shinohara; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

2.  Anatomic-based three-dimensional planning precludes use of catheter-delivered contrast for treatment of prostate cancer.

Authors:  Melisa Boersma; Gregory Swanson; Diana Baacke; Tony Eng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

3.  Intrafractional motion of the prostate during hypofractionated radiotherapy.

Authors:  Yaoqin Xie; David Djajaputra; Christopher R King; Sabbir Hossain; Lijun Ma; Lei Xing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-01       Impact factor: 7.038

4.  How I Do It: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy.

Authors:  Juan Montoya; Eric Gross; Lawrence Karsh
Journal:  Can J Urol       Date:  2018-04       Impact factor: 1.344

Review 5.  MRI for patients with cardiac implantable electrical devices.

Authors:  Grant V Chow; Saman Nazarian
Journal:  Cardiol Clin       Date:  2014-02-12       Impact factor: 2.213

6.  Frequency of referral of patients with safety-related contraindications to magnetic resonance imaging.

Authors:  Marc Dewey; Tania Schink; Charles F Dewey
Journal:  Eur J Radiol       Date:  2007-03-23       Impact factor: 3.528

7.  Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.

Authors:  Daniel A Hamstra; Neil Mariados; John Sylvester; Dhiren Shah; Lawrence Karsh; Richard Hudes; David Beyer; Steven Kurtzman; Jeffrey Bogart; R Alex Hsi; Michael Kos; Rodney Ellis; Mark Logsdon; Shawn Zimberg; Kevin Forsythe; Hong Zhang; Edward Soffen; Patrick Francke; Constantine Mantz; Peter Rossi; Theodore DeWeese; Stephanie Daignault-Newton; Benjamin W Fischer-Valuck; Anupama Chundury; Hiram Gay; Walter Bosch; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-23       Impact factor: 7.038

8.  External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?

Authors:  Kevin S Choe; Ashesh B Jani; Stanley L Liauw
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-20       Impact factor: 7.038

9.  Time course of late rectal toxicity after radiation therapy for prostate cancer.

Authors:  K Odrazka; M Dolezel; J Vanasek; M Vaculikova; M Zouhar; J Sefrova; P Paluska; M Vosmik; T Kohlova; I Kolarova; Z Macingova; P Navratil; M Brodak; P Prosvic
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-12-29       Impact factor: 5.554

10.  Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.

Authors:  Mark E Hwang; Mark Mayeda; Maria Liz; Brenda Goode-Marshall; Lissette Gonzalez; Carl D Elliston; Catherine S Spina; Oscar A Padilla; Sven Wenske; Israel Deutsch
Journal:  Radiat Oncol       Date:  2019-08-02       Impact factor: 3.481

View more
  2 in total

1.  Case Report: Role of an Iodinated Rectal Hydrogel Spacer, SpaceOAR Vue™, in the Context of Low-Dose-Rate Prostate Brachytherapy, for Enhanced Post-Operative Contouring to Aid in Accurate Implant Evaluation and Dosimetry.

Authors:  Andrew Gross; Jiankui Yuan; Daniel Spratt; Elisha Fredman
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

Review 2.  Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.

Authors:  Michael C Repka; Michael Creswell; Jonathan W Lischalk; Michael Carrasquilla; Matthew Forsthoefel; Jacqueline Lee; Siyuan Lei; Nima Aghdam; Shaan Kataria; Olusola Obayomi-Davies; Brian T Collins; Simeng Suy; Ryan A Hankins; Sean P Collins
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.